Markers of Oxidative Stress and Tyrosinase Activity in Melasma Patients: A Biochemical Investigation


Cite item

Full Text

Abstract

Background:Melasma, oxidative stress, tyrosinase, antioxidants, Homogenized skin tissues, hyperpigmentation disease.

Aims:To compare the levels of oxidative stress and tyrosinase activity in melasma patients with healthy volunteers.

Methods:After written consent, 130 patients were enrolled in a case–control study. 65 cases were of melasma disorder, and 65 were served as control. Homogenized skin tissues were taken and used to estimate superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx) (antioxidants), malondialdehyde (MDA) and tyrosine hydroxylase (TH).

Results:Melasma patients had lower basal levels of systemic antioxidants than healthy subjects. Tyrosinase activity was shown to be greater in lesional skin than in non-lesional skin. In controls, there was a good positive relationship between TH and MDA and an excellent negative relationship between GPx and GSH. In melasma patients, there were significant associations between CAT, GPx, SOD and MDA.

Conclusions:Increased oxidative stress may affect tyrosinase activity and eumelanin synthesis via the anabolic pathway of melanin synthesis, according to our findings. In conclusion, we discovered a negative relationship between antioxidants and tyrosinase activity.

About the authors

Shweta Katiyar

Department of Biochemistry, SBN Govt PG College

Author for correspondence.
Email: info@benthamscience.net

Dhananjay Yadav

Department of Medical Biotechnology, Yeungnam University

Author for correspondence.
Email: info@benthamscience.net

Sanjeev K. Singh

Department of Biochemistry, GR Medical College,

Email: info@benthamscience.net

References

  1. Ogbechie-Godec, O.A.; Elbuluk, N. Melasma: An up-to-date comprehensive review. Dermatol. Ther. (Heidelb.), 2017, 7(3), 305-318. doi: 10.1007/s13555-017-0194-1 PMID: 28726212
  2. Basit, H.; Godse, K.V.; Al Aboud, A.M. Melasma; StatPearls Publications: Treasure Island (FL), 2022.
  3. Tomar, A.; Purohit, S.; Gaur, K.; Kaur, M.; Kashyap, A. A case series of 500 melasma cases: A descriptive study. Int Multi J Health, 2017, 3(2), 34-39.
  4. Sarkar, R.; Gokhale, N.; Godse, K.; Ailawadi, P.; Arya, L.; Sarma, N.; Torsekar, R.G.; Somani, V.K.; Arora, P.; Majid, I.; Ravichandran, G.; Singh, M.; Aurangabadkar, S.; Arsiwala, S.; Sonthalia, S.; Salim, T.; Shah, S. Medical management of melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian J. Dermatol., 2017, 62(6), 450. doi: 10.4103/ijd.IJD_489_17 PMID: 29263529
  5. Sarkar, R.; Ailawadi, P.; Garg, S. Melasma in men a review of clinical, etiological, and management issues. J. Clin. Aesthet. Dermatol., 2018, 11(2), 53-59. PMID: 29552277
  6. Sarkar, R.; Ghunawat, S.; Narang, I.; Verma, S.; Garg, V.K.; Dua, R. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma. J. Cosmet. Dermatol., 2019, 18(4), 1066-1073. doi: 10.1111/jocd.12911 PMID: 31033184
  7. Nayak, C.S.; Nouveau, S.; Agrawal, D.; Kohli, M.; Bernerd, F.; Misra, N. Skin hyperpigmentation in Indian population: Insights and best practice. Indian J. Dermatol., 2016, 61(5), 487-495. doi: 10.4103/0019-5154.190103 PMID: 27688436
  8. Krupa, S.D.S. Melasma/chloasma/mark of pregnancy. Aestheticians J, 2012, 2(1), 7-11.
  9. Pichardo, R.; Vallejos, Q. The prevalence of melasma and its association with quality of life among adult male migrant latino workers. Int. J. Dermatol., 2009, 48(1), 22-26. doi: 10.1111/j.1365-4632.2009.03778.x PMID: 19126046
  10. Passeron, T.; Picardo, M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res., 2018, 31(4), 461-465. doi: 10.1111/pcmr.12684 PMID: 29285880
  11. Jiang, J.; Akinseye, O.; Tovar-Garza, A.; Pandya, A.G. The effect of melasma on self-esteem: A pilot study. Int. J. Womens Dermatol., 2018, 4(1), 38-42. doi: 10.1016/j.ijwd.2017.11.003 PMID: 29872675
  12. Aishwarya, K.; Bhagwat, P.V.; John, N. Current concepts in melasma- a review article. J Skin Sexually Trans Dis, 2019, 2(1), 13-17.
  13. Hollinger, J.C.; Angra, K.; Halder, R.M. Are natural ingredients effective in the management of hyperpigmentation? A systematic review. J. Clin. Aesthet. Dermatol., 2018, 11(2), 28-37. PMID: 29552273
  14. Espósito, A.C.C.; Brianezi, G.; de Souza, N.P.; Miot, L.D.B.; Marques, M.E.A.; Miot, H.A. Exploring pathways for sustained melanogenesis in facial melasma: An immunofluorescence study. Int. J. Cosmet. Sci., 2018, 40(4), 420-424. doi: 10.1111/ics.12468 PMID: 29846953
  15. Sonthalia, S.; Sarkar, R. Etiopathogenesis of melasma. Pigment International, 2015, 2(1), 21-27. doi: 10.4103/2349-5847.159389
  16. Gutteridge, J.M.C.; Halliwell, B. Mini-Review: Oxidative stress, redox stress or redox success? Biochem. Biophys. Res. Commun., 2018, 502(2), 183-186. doi: 10.1016/j.bbrc.2018.05.045 PMID: 29752940
  17. Zainuddin, F.; Anwar, A.I. The Correlation between malondialdehyde serum levels and the duration of sun exposure; and melasma area and severity index in patients with melasma in makassar. Am. J. Clin. Exp. Med., 2016, 4(3), 68-75. doi: 10.11648/j.ajcem.20160403.16
  18. Choubey, V.; Sarkar, R.; Garg, V.; Kaushik, S.; Ghunawat, S.; Sonthalia, S. Role of oxidative stress in melasma: A prospective study on serum and blood markers of oxidative stress in melasma patients. Int. J. Dermatol., 2017, 56(9), 939-943. doi: 10.1111/ijd.13695 PMID: 28681382
  19. Winterbourn, C.C.; Hawkins, R.E.; Brian, M.; Carrell, R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med., 1975, 85(2), 337-341. PMID: 803541
  20. Abei, H. Catalase in vitro. Methods Enzymol., 1984, 105, 121-6.
  21. Brehe, J.E.; Burch, H.B. Enzymatic assay for glutathione. Anal. Biochem., 1976, 74(1), 189-197. doi: 10.1016/0003-2697(76)90323-7 PMID: 962073
  22. Paglia, D.E.; Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 1967, 70(1), 158-169. PMID: 6066618
  23. Jean, C.D.; Maryse, T.; Marie, J.F. Plasma malondialdehyde levels during myocardial infarction. Clin. Chim. Acta, 1983, 129, 31922.
  24. Kim, M.; Shibata, T.; Kwon, S.; Park, T.J.; Kang, H.Y. Ultraviolet-irradiated endothelial cells secrete stem cell factor and induce epidermal pigmentation. Sci. Rep., 2018, 8(1), 4235. doi: 10.1038/s41598-018-22608-y PMID: 29523807
  25. Katiyar, S.; Yadav, D. Correlation of oxidative stress with melasma: An overview. Curr. Pharm. Des., 2022, 28(3), 225-231. doi: 10.2174/1381612827666211104154928 PMID: 34736377
  26. Sarkar, R.; Bansal, S. Skin pigmentation in relation to gender: Truth and myth. Pigment International, 2017, 4(1), 1-2. doi: 10.4103/2349-5847.208350
  27. Im, S.; Lee, E.S.; Kim, W.; On, W.; Kim, J.; Lee, M.; Kang, W.H. Donor specific response of estrogen and progesterone on cultured human melanocytes. J. Korean Med. Sci., 2002, 17(1), 58-64. doi: 10.3346/jkms.2002.17.1.58 PMID: 11850590
  28. Kumre, K.; Varma, K.; Sharma, H.; Singh, U. Study of hormonal profile in female melasma patients in a tertiary care hospital. J. Evol. Med. Dent. Sci., 2016, 5(31), 1663-1666. doi: 10.14260/jemds/2016/392
  29. Ertam, I.; Ozkapu, T. Antioxidant activity in melasma. Turkderm-Turk Arch Dermatol Venereol, 2018, 52, 33-36.
  30. Zamani, M. Melasma: A brief overview of classification and treatment modalities. In: Aesthetics J; , 2016; 2016, .
  31. Hamadi, S.A.; Mohammed, M.M.; Aljaf, A.N.; Ali Abdulrazak, A. The role of topical and oral melatonin in management of melasma patients. J Arab Uni Basic Applied Sci, 2009, 8, 30-32.
  32. Seçkin, H.Y.; Kalkan, G.; Baş, Y.; Akbaş, A.; Önder, Y.; Özyurt, H.; Şahin, M. Oxidative stress status in patients with melasma. Cutan. Ocul. Toxicol., 2014, 33(3), 212-217. doi: 10.3109/15569527.2013.834496 PMID: 24147944
  33. Kowalczyk, P.; Sulejczak, D.; Kleczkowska, P.; Bukowska-Ośko, I.; Kucia, M.; Popiel, M.; Wietrak, E.; Kramkowski, K.; Wrzosek, K.; Kaczyńska, K. Mitochondrial oxidative stress- a causative factor and therapeutic target in many diseases. Int. J. Mol. Sci., 2021, 22(24), 13384. doi: 10.3390/ijms222413384 PMID: 34948180
  34. Xing, X.; Dan, Y.; Xu, Z.; Xiang, L. Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders. Oxid. Med. Cell. Longev., 2022, 2022, 1-12. doi: 10.1155/2022/7881717 PMID: 35087618
  35. Conrad, M.; Kagan, V.E.; Bayir, H.; Pagnussat, G.C.; Head, B.; Traber, M.G.; Stockwell, B.R. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev., 2018, 32(9-10), 602-619. doi: 10.1101/gad.314674.118 PMID: 29802123
  36. Salmon, T.B.; Evert, B.A.; Song, B.; Doetsch, P.W. Biological consequences of oxidative stress-induced DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res., 2004, 32(12), 3712-3723. doi: 10.1093/nar/gkh696 PMID: 15254273
  37. Babbush, K.; Babbush, R.; Khachemoune, A. The therapeutic use of antioxidants of melasma. J. Drugs Dermatol., 2020, 19(8), 788-792. doi: 10.36849/JDD.2020.5079 PMID: 32845595
  38. D’Mello, S.; Finlay, G.; Baguley, B.; Askarian-Amiri, M. Signaling pathways in melanogenesis. Int. J. Mol. Sci., 2016, 17(7), 1144. doi: 10.3390/ijms17071144 PMID: 27428965
  39. Kang, H.Y.; Suzuki, I.; Lee, D.J.; Ha, J.; Reiniche, P.; Aubert, J.; Deret, S.; Zugaj, D.; Voegel, J.J.; Ortonne, J.P. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J. Invest. Dermatol., 2011, 131(8), 1692-1700. doi: 10.1038/jid.2011.109 PMID: 21562572

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers